Cargando…
A Novel Cell Line Based Orthotopic Xenograft Mouse Model That Recapitulates Human Hepatoblastoma
Currently, preclinical testing of therapies for hepatoblastoma (HB) is limited to subcutaneous and intrasplenic xenograft models that do not recapitulate the hepatic tumors seen in patients. We hypothesized that injection of HB cell lines into the livers of mice would result in liver tumors that res...
Autores principales: | Woodfield, Sarah E., Shi, Yan, Patel, Roma H., Jin, Jingling, Major, Angela, Sarabia, Stephen F., Starosolski, Zbigniew, Zorman, Barry, Gupta, Siddharth S., Chen, Zhenghu, Ibarra, Aryana M., Bissig, Karl-Dimiter, Ghaghada, Ketan B., Sumazin, Pavel, López-Terrada, Dolores, Vasudevan, Sanjeev A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5736579/ https://www.ncbi.nlm.nih.gov/pubmed/29259231 http://dx.doi.org/10.1038/s41598-017-17665-8 |
Ejemplares similares
-
MDM4 inhibition: a novel therapeutic strategy to reactivate p53 in hepatoblastoma
por: Woodfield, Sarah E., et al.
Publicado: (2021) -
Author Correction: MDM4 inhibition: a novel therapeutic strategy to reactivate p53 in hepatoblastoma
por: Woodfield, Sarah E., et al.
Publicado: (2021) -
HepT1-derived murine models of high-risk hepatoblastoma display vascular invasion, metastasis, and circulating tumor cells
por: Woodfield, Sarah E., et al.
Publicado: (2022) -
Targeting LRH-1 in hepatoblastoma cell lines causes decreased proliferation
por: Jin, Jingling, et al.
Publicado: (2019) -
Hepatoblastomas with carcinoma features represent a biological spectrum of aggressive neoplasms in children and young adults
por: Sumazin, Pavel, et al.
Publicado: (2022)